3185 results for «8008»

Filter By

3185 results

TAVI for pure aortic regurgitation: different animal, different challenges, different approaches

17 Nov 2025 – From PCR London Valves 2025

This session delves into the unique anatomical and pathophysiological challenges posed by pure aortic regurgitation and their impact on treatment strategies. It reviews clinical outcomes with established and new transcatheter devices, and presents emerging technologies that promise to advance therapeutic options for this distinct patient population.

TAVI for pure aortic regurgitation: different animal, different challenges, different approaches

Mitral TEER and LAA closure - LIVE Case

17 Nov 2025 – From PCR London Valves 2025

Watch a LIVE case followed by a recorded case regarding a 91-year-old female with permanent AF, LAD PCI three months earlier, and recurrent GID bleeding who presented with symptomatic severe primary mitral regurgitation due to P2 prolapse and flail. CT imaging showed a LAA with a...

Mitral TEER and LAA closure -  LIVE Case

From diagnosis to device: decision-making and planning for mitral valve interventions

17 Nov 2025 – From PCR London Valves 2025

This session offers a comprehensive overview of decision-making and procedural planning for transcatheter mitral valve interventions. It emphasizes patient-specific factors, advanced imaging for valve morphology assessment, device selection, and the integration of emerging technologies to tailor optimal treatment strategies for mitral valve disease.

From diagnosis to device: decision-making and planning for mitral valve interventions

Complications of valve-in-valve TAVI

18 Nov 2025 – From PCR London Valves 2025

This session addresses the complex complications associated with valve-in-valve TAVI procedures. Topics include delayed coronary compromise, unexpected clinical scenarios, the importance of recognizing surgical bioprosthesis types, the dual role of calcium in TAVI, and intricate left ventricular complications that can arise post valve-in-valve interventions.

TAVI embolisation - Part 2

18 Nov 2025 – From PCR London Valves 2025

This session focuses on managing complications related to TAVI valve embolisation and migration. It includes detailed case discussions on balloon-expandable valve dislocation into the left ventricle, intra-annular migration managed by valve-in-valve techniques, and successful strategies for self-expanding valve migration. The session underscores the importance of readiness...

Transcatheter tricuspid valve replacement: pioneering techniques and solutions for high-risk patients

18 Nov 2025 – From PCR London Valves 2025

This session explores advanced transcatheter tricuspid valve replacement techniques and outcomes. It features cases of TricValve dysfunction due to intrinsic regurgitation, pioneering 'chimney technique' implantation in complex patients, right heart remodeling post-intervention, and innovative solutions including percutaneous heterotopic bicaval valve implantation following pericardiectomy.

Transcatheter tricuspid valve replacement: pioneering techniques and solutions for high-risk patients

Mitral TEER in complex scenarios

18 Nov 2025 – From PCR London Valves 2025

This session presents complex clinical scenarios in mitral transcatheter edge-to-edge repair (TEER), illustrating advanced procedural techniques and multidisciplinary management. Topics include on-circuit aspiration thrombectomy to facilitate TEER, combined interventions addressing multiple valve pathologies, timing considerations in healed mitral endocarditis, and TEER application in end-stage idiopathic cardiomyopathy....

Complex mitral and tricuspid TEER

16 Nov 2025 – From PCR London Valves 2025

This session highlights complex cases in mitral and tricuspid transcatheter edge-to-edge repair (TEER), addressing challenges such as septal obstacles in patients with old atrial septal occluders, management of residual atrial septal defects post-mitral valve-in-ring replacement, and innovative multidisciplinary approaches. It also covers hybrid transapical mitral valve-in-valve...

Retrieval of embolised devices

16 Nov 2025 – From PCR London Valves 2025

This session delves into the complex scenarios of embolised device retrieval, exploring various interventions such as management of Lambre device embolisation, alternatives to surgery for superior vena cava baffle stent embolisation, novel strategies for chronically embolised Gore Helex atrial septal occluder device retrieval, and challenging redo...

Late-breaking evidence in structural and coronary interventions - Part 2

16 Nov 2025 – From PCR London Valves 2025

This session presents the latest data from pivotal late-breaking trials in interventional cardiology. Highlights include one-year results from the ADALA trial, first-in-man use of the Vivasure PerQseal Elite for large hole arterial closure, two-year outcomes of the DragonFly system in China, six-month European outcomes, and insights...

The Top Late-Breaking Trials - Part 2

PCR London Valves 2025 Welcome Ceremony

16 Nov 2025 – From PCR London Valves 2025

The PCR London Valves 2025 Welcome Ceremony marks the commencement of the conference, setting the stage for an immersive exploration of the latest advances and innovations in valvular heart disease management with a focus on transcatheter interventions.

PCR London Valves 2025 Welcome Ceremony

Redo TAVI with pre and post dilatation - LIVE Case

16 Nov 2025 – From PCR London Valves 2025

Watch this live case followed by a live in a box case, regarding a 93-year-old woman with hypertension, chronic bronchitis, and a history of TAVI with a Sapien 3 23 mm (2016) who presented with symptomatic severe aortic stenosis and mildly reduced LV function (50%). An...

Redo TAVI with pre and post dilatation - LIVE Case

The Silk Road of MedTech

16 Nov 2025 – From PCR London Valves 2025

Discover pioneering MedTech innovations along the Silk Road, including novel sheath designs for minimalist TAVR, self-expanding valves for pure aortic regurgitation, automated CT quantification via deep learning, and first-in-man experiences with cutting-edge valvuloplasty and TEER devices.

Innovations in TAVR: clinical insights and future perspectives

16 Nov 2025 – From PCR London Valves 2025

Presenting featured research on TAVI, this session covers outcomes from centers without on-site cardiac surgery, comparative leaflet modification techniques, conscious sedation protocols, left ventricular health in timing TAVR, and long-term valve durability insights including seven-year follow-up data.

Innovations in TAVR: clinical insights and future perspectives

Cutting-edge research in transcatheter tricuspid valve therapies

16 Nov 2025 – From PCR London Valves 2025

This session highlights cutting-edge research on tricuspid valve interventions, including the impact of inflow gradients on outcomes, global registry data on bicaval valve therapy, patient selection algorithms, and prognostic score validations for severe tricuspid regurgitation.

Cutting-edge research in transcatheter tricuspid valve therapies

TAVI in bicuspid anatomy

16 Nov 2025 – From PCR London Valves 2025

Explore the complexities of performing TAVI in bicuspid aortic valve anatomies, with expert discussions on BASILICA tricuspidisation, procedural planning for extreme calcification, valve sizing, and challenges associated with type 0 bicuspid valves and severe calcification.

New approaches in aortic regurgitation

16 Nov 2025 – From PCR London Valves 2025

Explore new diagnostic and therapeutic approaches for managing aortic regurgitation. This session covers imaging modalities, guideline-directed patient selection, current transcatheter treatment techniques, and emerging TAVI technologies designed specifically for non-calcific aortic valve pathology.

New approaches in aortic regurgitation

Rapid fire on ortothopic TTVR

16 Nov 2025 – From PCR London Valves 2025

This rapid-fire session presents an overview of the latest orthotopic transcatheter tricuspid valve replacement (TTVR) devices. It features concise discussions on multiple innovative systems including Evoque, Laplace, VDyne, Topaz, and Cardiovalve, offering insights into their design characteristics and clinical applications in tricuspid valve disease management.

Complications of paravalvular leak closure

18 Nov 2025 – From PCR London Valves 2025

This session addresses the complexities and risks associated with paravalvular leak (PVL) closure. It offers detailed analysis of principal complications, prevention techniques, and practical management strategies shared by experienced operators. Case studies illustrate complications such as device embolisation, prosthetic valve disc impingement, and delivery failures, along...

Tales of structural heart innovation: happiness follows pain and sweat - Session 2

25 Nov 2024 – From PCR London Valves 2024

Tales of structural heart innovation: happiness follows pain and sweat - Session 2
Didn’t find what you were looking for?